• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer.

作者信息

Cao Yunfei, Wu Liucheng, Tan Aihua, Liu Lidan, Liao Cun, Gao Feng

出版信息

Pancreas. 2010 Mar;39(2):253-5. doi: 10.1097/MPA.0b013e3181bdc6b8.

DOI:10.1097/MPA.0b013e3181bdc6b8
PMID:20182311
Abstract
摘要

相似文献

1
Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer.随机试验的荟萃分析：基于吉西他滨的分子靶向治疗对不可切除胰腺癌的疗效评估
Pancreas. 2010 Mar;39(2):253-5. doi: 10.1097/MPA.0b013e3181bdc6b8.
2
Gemcitabine doublets in advanced pancreatic cancer: should we move on?晚期胰腺癌中的吉西他滨双联方案：我们是否应继续采用？
J Clin Oncol. 2006 Jan 20;24(3):327-9. doi: 10.1200/JCO.2005.03.8315. Epub 2005 Dec 12.
3
[Pancreatic carcinoma: progress in therapy].
Krankenpfl J. 2004;42(5-6):158-9.
4
Efficacy and safety profile of combining agents against epidermal growth factor receptor or vascular endothelium growth factor receptor with gemcitabine-based chemotherapy in patients with advanced pancreatic cancer: a meta-analysis.联合表皮生长因子受体或血管内皮生长因子受体拮抗剂与吉西他滨为基础化疗治疗晚期胰腺癌患者的疗效和安全性：一项荟萃分析。
Pancreatology. 2013 Jul-Aug;13(4):415-22. doi: 10.1016/j.pan.2013.04.195. Epub 2013 Apr 28.
5
Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials.吉西他滨单药治疗与吉西他滨联合靶向治疗晚期胰腺癌：一项随机III期试验的荟萃分析
Acta Oncol. 2017 Mar;56(3):377-383. doi: 10.1080/0284186X.2017.1288922. Epub 2017 Feb 17.
6
Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials.吉西他滨联合治疗与单纯吉西他滨治疗晚期胰腺癌的比较：九项随机对照试验的荟萃分析
Hepatobiliary Pancreat Dis Int. 2017 Jun;16(3):236-244. doi: 10.1016/s1499-3872(17)60022-5.
7
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? (Review).转移性胰腺癌：吉西他滨仍是最佳标准治疗方法吗？（综述）
Oncol Rep. 2010 May;23(5):1183-92. doi: 10.3892/or_00000749.
8
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.随机试验的荟萃分析：评估吉西他滨为基础的联合化疗应用于晚期胰腺癌的获益情况。
BMC Cancer. 2008 Mar 28;8:82. doi: 10.1186/1471-2407-8-82.
9
Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.胰腺蛋白水解酶治疗与吉西他滨为基础的化疗治疗胰腺癌的比较。
J Clin Oncol. 2010 Apr 20;28(12):2058-63. doi: 10.1200/JCO.2009.22.8429. Epub 2009 Aug 17.
10
Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.吉西他滨联合S-1：亚洲不可切除晚期胰腺癌患者充满希望的一线治疗方案。
Jpn J Clin Oncol. 2015 Dec;45(12):1122-30. doi: 10.1093/jjco/hyv141. Epub 2015 Oct 30.

引用本文的文献

1
Outcome of gemcitabine plus molecular targeted agent for treatment of pancreatic cancer: a meta-analysis of prospective phase III studies.吉西他滨联合分子靶向药物治疗胰腺癌的疗效：前瞻性III期研究的荟萃分析
Tumour Biol. 2014 Nov;35(11):11551-8. doi: 10.1007/s13277-014-2451-6. Epub 2014 Aug 17.